Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/02/17
Trade details
- Type
- Insider sale
- Amount
- $902,440.44
- Shares · price
- 3,564 sh · $253.21 a share
- Held after
- 376 sh
- Trade date
- 23/02/15
- Filed
- 23/02/17
- Days to filing
- 2 days
Sold 90.5% of holdings
- Share of holding sold
- 90.5%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 23/01/16~23/03/17Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$775.2K
1,346 sh
$775.2K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$537.5K
930 sh
$537.5K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$501.3K
864 sh
$501.3K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$477.2K
830 sh
$477.2K
Filed 10/02
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$446.5K
774 sh
$446.5K
Filed 10/02
Traded 10/01